NCT06469671 2024-06-21
ArtInCol
State Scientific Centre of Coloproctology, Russian Federation
Phase NA Not yet recruiting
Clinical Trials
3 trialsNCT06218888 2024-01-23
A Phase II Clinical Study of the Efficacy and Safety of Tislelizumab Combined With Fruquintinib and Chidamide in the Treatment of Unresectable or Advanced Microsatellite Stabilized (MSS/pMMR) Colorectal Cancer With Liver Metastases
Fujian Cancer Hospital
Phase 2 Not yet recruiting
NCT06053996 2023-09-26
TROS-8
Sheba Medical Center
Phase NA Not yet recruiting